APGE Disposition Disclosure
Fairmount Funds Management Llc · SEC Form 4 · Filed Sep 3, 2026
Disposition
Reported value range
Not reported
Fairmount Funds Management Llc Director
APGE
Apogee Therapeutics
APGE
Transaction date
Sep 3, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed same day
APGE daily price context
Close on/before transaction
$135.07
Sep 3, 2026
Close before public filing
$135.07
Sep 2, 2026
Return since public filing
0.0%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 10,370 shares
- SEC ownership
- Indirect
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001104659-26-105119
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Apogee Therapeutics, Inc. APGE | Disposition | Sep 3, 2026 | Not reported |
| Apogee Therapeutics, Inc. APGE | Disposition | Sep 3, 2026 | Not reported |
| Apogee Therapeutics, Inc. APGE | Disposition | Sep 3, 2026 | Not reported |
| Apogee Therapeutics, Inc. APGE | Disposition | Sep 3, 2026 | Not reported |
| Apogee Therapeutics, Inc. APGE | Disposition | Sep 3, 2026 | Not reported |
| Apogee Therapeutics, Inc. APGE Current | Disposition | Sep 3, 2026 | Not reported |
| Apogee Therapeutics, Inc. APGE | Disposition | Sep 3, 2026 | Not reported |
| Apogee Therapeutics, Inc. APGE | Disposition | Sep 3, 2026 | Not reported |